Medtronic valve replacement tops surgery after 2 years -study

March 15 (Reuters) - Patients treated with Medtronic Plc's CoreValve non-invasive heart valve replacement system fared better two years after the procedure than those who underwent surgical valve replacement, according to data from a study presented on Sunday.